Evidence map›Paper›PMID 38482253›Full record

ArticleJournal of gastrointestinal oncology2024

Upregulated expression of

Yu He, Zhangyan Du, Honghua Peng, Abhinav V Reddy, Peiguo Cao

Open access · diamondAbstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yu He *Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, China.
Zhangyan Du *Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, China.
Honghua PengDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, China.
Abhinav V ReddyDepartment of Radiation Oncology & Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Sidney Kimmel Cancer Center, Baltimore, MD, USA.
Peiguo CaoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, China.
Central South University · CNJohns Hopkins University · USThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pancreatic cancer (PC) is an aggressive disease with a very poor prognosis. The insidious onset, rapid progression, and resistance to conventional therapies mark the imperious need for novel biomarkers and therapeutic targets. The pituitary tumor transforming gene 1 ( Methods: The present study examined the Results: Conclusions: The upregulated expression of

Indexed as

bioinformaticsimmunohistochemistry (IHC)Pancreatic cancer (PC)pituitary tumor transforming gene 1 (PTTG1)prognosis

Identifiers

PMID38482253
PMCPMC10932678
OpenAlexW4392301550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.